Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 2 More Arrow 1,813
Earnings before taxes -44,628 More Arrow -38,523 Less Arrow -50,850
EBITDA -44,752 More Arrow -38,521 Less Arrow -49,964
Total assets 27,112 More Arrow 34,695 More Arrow 51,478
Current assets 25,240 More Arrow 31,830 More Arrow 49,460
Current liabilities 8,053 Less Arrow 6,173 Less Arrow 5,909
Equity capital 19,059 More Arrow 28,522 More Arrow 45,569
- share capital 5,811 Less Arrow 2,419 More Arrow 26,768
Employees (average) 4 More Arrow 5 Equal arrow 5

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 70.3% More Arrow 82.2% More Arrow 88.5%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -164.6% More Arrow -111.0% More Arrow -95.3%
Current ratio 313.4% More Arrow 515.6% More Arrow 837.0%
Return on equity (ROE) -234.2% More Arrow -135.1% More Arrow -111.6%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -1 More Arrow 0 More Arrow 1
Chg. No. of employees % -20% More Arrow 0% More Arrow 25%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.